📋 Tender Overview
Modern biotechnology has developed into an integral part of the economy. Patents play an important role in making research in the life sciences and its implementation into marketable products profitable. This is particularly true for the pharmaceutical industry. Due to the importance of strong patent protection in creating legal certainty, strengthening the business location and creating new knowledge for the benefit of the general public, the European Directive on the Legal Protection of Biotechnological Inventions (Biopatent Directive) has been in place since 1998 in order to harmonize national patent regulations. In Austria, the Biopatent Directive was implemented in 2005 with an amendment to the Patent Act.
As part of this implementation, the Biopatent Monitoring Committee was entrusted with the task of reviewing the impact of Austrian legislation in the field of biopatents on a wide range of areas (human rights, animals, plants, ecological systems, consumer protection, agriculture and developing countries). To this end, the committee submits a report with the results of its reviews every three years. The committee's seventh report is currently available, covering the period from 2021 to 2023.
